Panel Discussion: Clinical Trials in a Dish? Modeling Neurodegenerative Disease with iPSCs

This thought-leading panel discussion highlighted the benefits and challenges of using iPSCs in global R&D for neurodegenerative disease.

Expert panelists from academia, industry, service/product providers, and funding bodies, discussed the utility and application of iPSCs in this space, whilst also talking openly about the challenges that scientists face in using them.

Occurred on: 7th December 2021

Time: 6pm CET / 5pm GMT / 12pm ET/ 8am PT


  • Amy Pooler, VP Neuroscience, Sangamo
  • Charlie Arber, Senior Research Fellow, UCL
  • Dan Felsenfeld, Director Stem Cell Biology and Regenerative Medicine, CHDI
  • Ash Barnes, CSO, Axol Bioscience Ltd
Copyright © 2021 Axol Bioscience. All Rights Reserved. 
B260 Meditrina | Babraham Research Campus | Cambridge | CB22 3AT | UK
 Phone: +44 (0) 1223 751051 | US Toll Free: 1-800-678-AXOL (2965)